← Back to browse
HR 3164 Cleared committee

Adds pharmacist services to Medicare Part B, covering pharmacist evaluation, testing, and treatment for COVID-19, influenza, RSV, and strep throat, paid at 80 percent of a set rate.

Official title: Ensuring Community Access to Pharmacist Services Act

Next stop House floor: awaiting a vote
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Introduced 01-MAY-2025
Referred 01-MAY-2025
Approved by committee 21-MAY-2026
Key points
  • Covers pharmacist visits and testing or treatment for COVID-19, influenza, respiratory syncytial virus, or streptococcal pharyngitis, plus other services that address a public health emergency need as determined by the Secretary of Health and Human Services.
  • Limits covered pharmacist services to those state law allows a pharmacist to perform, including any physician supervision or collaboration that state law requires.
  • Pays 80 percent of the lesser of the actual charge or 85 percent of the physician fee schedule amount, or 100 percent of that amount for public health emergency services.
  • Extends existing balance billing limits to pharmacists and applies to items and services furnished on or after January 1, 2026.
AI-generated from the Introduced in House text of 01-MAY-2025 · verify · report an error
Official CRS summary

Current. The Congressional Research Service's summary covers the bill's latest wording (Introduced in House, 01-MAY-2025).

CRS is the Library of Congress's nonpartisan research office. Read it on congress.gov
Committee referrals (2) Policy area

Health

Sponsor Adrian Smith (R-NE) Cosponsors · 143
■ 80 R■ 63 D